{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "60001035",
    "licUnit": "1",
    "validDate": "2026-12-22 00:00:00.000",
    "issueDate": "2016-12-22 00:00:00.000",
    "oriIssueDate": "2016-12-22",
    "licKind": "04",
    "oldLicid": null,
    "certNo": "DHA06000103503",
    "prodNameC": "類希瑪",
    "prodNameE": "Remsima",
    "indicationsName": [
        "1、克隆氏症：適用於對傳統治療無效之成人中度至重度活動性克隆氏症，可減輕症狀與徵兆及誘導與維持臨床緩解；適用於對傳統治療(包含抗生素、引流與免疫抑制劑)反應不佳之成人活動性瘻管性克隆氏症。\r\n2、小兒克隆氏症：適用於對皮質類固醇及免疫調節劑(immunomodulators)反應不佳之小兒(6-17 歲)中度至重度活動性克隆氏症，可減輕症狀與徵兆及誘導與維持臨床緩解。\r\n3、潰瘍性結腸炎：適用於皮質類固醇和6-mercaptopurine (6-MP)或azathioprine (AZA)等傳統治療無效、無法耐受或有醫療禁忌之中度至重度活動性潰瘍性結腸炎成人病人。\r\n4、小兒潰瘍性結腸炎：適用於對皮質類固醇和6-mercaptopurine (6-MP)或azathioprine (AZA)等傳統治療無效、無法耐受或有醫療禁忌之中度至重度動性潰瘍性結腸炎小兒(6-17 歲)病人。\r\n5、類風溼性關節炎：與methotrexate 併用，減緩中度到重度活動性疾病病人的徵兆及症狀，抑制結構性損傷的惡化，經HAQ-DI 量表評估，可改善日常生活功能。\r\n6、僵直性脊椎炎：減緩活動性疾病病患的徵兆及症狀。"
    ],
    "does": "2243",
    "packageUnit": [
        {
            "packageSpec": "100毫克",
            "packageUnit": "L2"
        },
        {
            "packageSpec": "100支以下",
            "packageUnit": "03"
        }
    ],
    "medMCode": "05",
    "maMedCode": "",
    "medDCode": "D",
    "mainCategory": "D",
    "drBaseId": "DB11E100-B7C4-4C54-8A31-BE5DB81F6FA0",
    "subCategory": [],
    "ingredientsDesc": [
        "Infliximab"
    ],
    "restraintItemsCode": [
        "02 輸 入",
        "07 新藥監視",
        "1D 須執行風險管理計畫",
        "1E 須執行Phase IV Study",
        "5F 免除銜接性試驗",
        "68 成品已完成元素不純物評估(Option 3)",
        "91 生物相似性藥品"
    ],
    "applicantName": "台灣賽特瑞恩有限公司",
    "applicantAddr": "臺北市信義區松仁路97號3樓之1",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": "2021-12-22",
    "licidNew": null,
    "licidOld": null,
    "manuImportDesc": "廠商未登錄資料",
    "licManuImport": "2",
    "factoryDtoList": [
        {
            "id": "1B9E4EE0-9F16-4155-BD75-9FC2FFEC54A3",
            "factoryCode": "1",
            "factoryName": "CELLTRION INC.",
            "factoryAddr": "20, ACADEMY-RO, 51BEON-GIL, YEONSU-GU, INCHEON, 22014, REPUBLIC OF KOREA",
            "factoryCompanyAddr": null,
            "countryCode": "KR",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FKR0182100",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "23DE1328-8A26-4B6D-9008-AC4B58899236",
            "factoryCode": "2",
            "factoryName": "CELLTRION INC.",
            "factoryAddr": "23, ACADEMY-RO, YEONSU-GU, INCHEON, 22014, REPUBLIC OF KOREA",
            "factoryCompanyAddr": null,
            "countryCode": "KR",
            "processCode": [
                {
                    "value": "1K",
                    "name": "原料藥製造廠"
                }
            ],
            "processCodeStr": "1K;原料藥製造廠",
            "factoryKind": "M",
            "factoryNo": "FKR0182000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "9200081100",
            "ingredientsName": "Infliximab",
            "ingredientsDesc": "Infliximab",
            "concentDesc": "",
            "concent": "100.000000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L04AB02"
        }
    ],
    "udiInfoList": [],
    "licBaseId": "8DFF0657-BFC1-4EF4-8D3A-273839DB9B9D"
}